GL1X · GenesisL1 explorer

UniProt Q8E378

Peptide deformylase (Q8E378)

Peptide deformylase (UniProt Q8E378), EC 3.5.1.88: 24 experimental structures and 1 predicted model on GenesisL1, 10 ligands bound, 5 pockets. Binding sites, druggability and experiment against prediction (TM-score) in GL1X.

UniProt
Q8E378
Protein
Peptide deformylase
EC
3.5.1.88
Experimental structures
24
Predicted models
1
Ligands
10
Pockets
5 · 4 records with a druggable one

Structures

25 records of Q8E378 in the MolNFT archive: 24 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
5JEXCrystal structure of type 2 PDF from Streptococcus agalactiae, crystallized in imidazole bufferx-ray diffractionAZN—
5JEXCrystal structure of type 2 pdf from streptococcus agalactiae, crystallized in imidazole bufferx-ray diffractionA——
5JEYCrystal structure of type 2 PDF from Streptococcus agalactiae, crystallized in cacodylate bufferx-ray diffractionANI—
5JEYCrystal structure of type 2 pdf from streptococcus agalactiae, crystallized in cacodylate bufferx-ray diffractionA——
5JEZCrystal structure of type 2 PDF from Streptococcus agalactiae in complex with tripeptide Met-Ala-Serx-ray diffractionAZN—
5JEZCrystal structure of type 2 pdf from streptococcus agalactiae in complex with tripeptide met-ala-serx-ray diffractionA——
5JF0Crystal structure of type 2 PDF from Streptococcus agalactiae in complex with tripeptide Met-Ala-Argx-ray diffractionANI—
5JF0Crystal structure of type 2 pdf from streptococcus agalactiae in complex with tripeptide met-ala-argx-ray diffractionA——
5JF1Crystal structure of type 2 PDF from Streptococcus agalactiae in complex with actinoninx-ray diffractionABB2, ZN1 (best 0.51)
5JF1Crystal structure of type 2 pdf from streptococcus agalactiae in complex with actinoninx-ray diffractionA——
5JF2Crystal structure of type 2 PDF from Streptococcus agalactiae in complex with inhibitor AT002x-ray diffractionASF7, ZN1 (best 0.53)
5JF2Crystal structure of type 2 pdf from streptococcus agalactiae in complex with inhibitor AT002x-ray diffractionA——
5JF3Crystal structure of type 2 PDF from Streptococcus agalactiae in complex with inhibitor AT018x-ray diffractionASF5, ZN—
5JF3Crystal structure of type 2 pdf from streptococcus agalactiae in complex with inhibitor AT018x-ray diffractionA——
5JF4Crystal structure of type 2 PDF from Streptococcus agalactiae in complex with inhibitor AT019x-ray diffractionA6JT, ZN1 (best 0.52)
5JF4Crystal structure of type 2 pdf from streptococcus agalactiae in complex with inhibitor AT019x-ray diffractionA——
5JF5Crystal structure of type 2 PDF from Streptococcus agalactiae in complex with inhibitor AT020x-ray diffractionA7JT, ZN1 (best 0.51)
5JF5Crystal structure of type 2 pdf from streptococcus agalactiae in complex with inhibitor AT020x-ray diffractionA——
5JF6Crystal structure of type 2 PDF from Streptococcus agalactiae in complex with inhibitor 6b (AB47)x-ray diffractionABB4, ZN1 (best 0.48)
5JF6Crystal structure of type 2 pdf from streptococcus agalactiae in complex with inhibitor 6B (AB47)x-ray diffractionA——
5JF7Crystal structure of type 2 PDF from Streptococcus agalactiae in complex with inhibitor SMP289x-ray diffractionA6JU, ZN—
5JF7Crystal structure of type 2 pdf from streptococcus agalactiae in complex with inhibitor SMP289x-ray diffractionA——
5JF8Crystal structure of type 2 PDF from Streptococcus agalactiae in complex with inhibitor RAS358 (21)x-ray diffractionAPN3, ZN—
5JF8Crystal structure of type 2 pdf from streptococcus agalactiae in complex with inhibitor RAS358 (21)x-ray diffractionA——
Q8E378AlphaFold monomer V2.0 prediction for peptide deformylase (Q8E378)predictedA——

Ligands

  • ZN · Zinc ion · in 10 records
  • NI · Nickel (II) ion · in 2 records
  • 6JT · (3R)-3-{3-[(1-benzofuran-3-yl)methyl]-1,2,4-oxadiazol-5-yl}-4-cyclopentyl-N-hydroxybutanamide · in 1 record
  • 6JU · 2-(3-benzyl-5-bromo-1H-indol-1-yl)-N-hydroxyacetamide · in 1 record
  • 7JT · (3R)-3-{3-[(2H-1,3-benzodioxol-5-yl)methyl]-1,2,4-oxadiazol-5-yl}-4-cyclopentyl-N-hydroxybutanamide · in 1 record
  • BB2 · Actinonin · in 1 record
  • BB4 · 2-(5-bromo-1H-indol-3-yl)-N-hydroxyacetamide · in 1 record
  • PN3 · tert-butyl {(2S)-1-[formyl(hydroxy)amino]-3-phenylpropan-2-yl}carbamate · in 1 record
  • SF5 · methyl 4-({5-[(3R)-1-(hydroxyamino)-1-oxoheptan-3-yl]-1,2,4-oxadiazol-3-yl}methyl)benzoate · in 1 record
  • SF7 · (3R)-3-{3-[(4-fluorophenyl)methyl]-1,2,4-oxadiazol-5-yl}-N-hydroxyheptanamide · in 1 record

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.